Dashboard
My Portfolio
Backtest
New
Portfolios
Investors
Analysts
Community
Calendars
Economic Calendar
Dividend Calendar
Earnings Calendar
Splits Calendar
IPO Calendar
Markets
Stocks
Indices
Forex
Crypto
Commodities
News
Sign Up
Sign In
Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
Bristol-Myers Squibb Company (BMY)
Market Closed
16 Oct, 08:00 PM
NYSE
All
(16)
DE
(7)
AT
(1)
CH
(1)
PE
(1)
MX
(1)
IT
(2)
GB
(2)
US
(1)
NYSE
Primary
LSE
XMIL
XWBO
BVL
XMEX
XDUS
XFRA
XHAN
XETRA
XSTU
XMUN
XSTU
XMIL
CBOE
SIX
$
59.
75
-0.82
-1.3538%
After Hours
$
60.
86
+1.11
+1.8577%
121.7B
Market Cap
-
P/E Ratio
2.52%
Div Yield
12.79M
Volume
-
Eps
$
60.57
Previous Close
Investors:
TJD
DI
LC
+791
Watching
Watch
Add Transaction
Day Range
59.55
61.43
Year Range
42.52
68.64
Want to track
BMY
and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Overview
Dividends
Earnings
Splits
Statistics
News
Historical Data
Investors
Bristol-Myers Squibb Company (BMY) Statistics
Valuation metrics
Market Cap
121.7B
Enterprise value
155.16B
Trailing P/E (ttm)
13.02
Forward P/E
9.62
PEG ratio
0.16
Price/Sales (ttm)
2.46
Price/Book (mrq)
5.41
Enterprise Value/Revenue
3.15
Enterprise Value/EBITDA
9.23
Overview
Shares outstanding
2.04B
Float
2.03B
Shares short
33.42M
% Held by insiders
0%
% Held by institutions
0.83%
Average volume (10 days)
12.39M
Average volume (90 days)
11.32M
Price summary
52-Week low
42.52
52-Week high
68.64
Beta
0.27
50-Day moving average
63.78
200-Day moving average
60.79
Dividends and splits
Forward annual dividend rate
2.52
Forward annual dividend yield
0.0427%
Trailing annual dividend rate
2.52
Trailing annual dividend yield
0.0426%
5-Year annual dividend yield
3.9%
Payout ratio
0.55
Dividend Date
3 Aug 2026
Ex-Dividend Date
2 Jul 2026
Last split factor
1,000,000:951,777
Last split Date
7 Aug 2001
Financials
Fiscal year
Fiscal year ends
31 Dec 2025
Most recent quarter (mrq)
31 Dec 2025
Profitability
Profit margin
0.19%
Operating margin
0.28%
Operational effectiveness
Return on assets
0.11%
Return on equity
0.47%
Income Statement
Revenue (ttm)
48.19B
Revenue per share (ttm)
24.09
Quarterly revenue growth (yoy)
0.01%
Gross profit (ttm)
35B
EBITDA
19.94B
Net income to common (ttm)
7.05B
Diluted EPS (ttm)
4.55
Quarterly earnings growth (yoy)
14.1%
Balance Sheet
Total cash (mrq)
10.67B
Total cash per share (mrq)
5.42
Total debt (mrq)
47.19B
Total Debt/Equity (mrq)
1.93
Current ratio (mrq)
1.53%
Book value per share (mrq)
10.93
Cash Flow
Cash flow statement
14.16B
Levered free cash flow (LFCF)
11.15B